Helping dogs with congestive heart failure (CHF) live longer, healthier lives is a top priority for Boehringer Ingelheim Vetmedica, Inc. That's why we support canine cardiology research and offer several programs to help veterinarians educate pet owners about the diagnosis and treatment of canine heart disease.
CE Webinar Series
The CE Webinar Series is an ongoing opportunity to learn about canine heart disease online—from the comfort of your own home or office. These online events are scheduled periodically throughout the year and are ideal for veterinarians who cannot attend a live dinner meeting.
Important safety information
VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons.
The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricular valvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure.